Charles River Laboratories International (CRL) Consolidated Net Income (2009 - 2025)

Charles River Laboratories International's Consolidated Net Income history runs 16 years deep, the most recent figure standing at -$276.3 million for Q4 2025.

• In Q4 2025, Consolidated Net Income fell 29.26% year-over-year to -$276.3 million; the TTM figure through Dec 2025 stood at -$142.2 million (down 662.11% YoY), while the FY2025 annual figure was -$142.2 million, down 662.11% from the prior year.
• Consolidated Net Income was -$276.3 million for Q4 2025 at Charles River Laboratories International, down from $55.6 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $189.1 million in Q4 2022 to a low of -$276.3 million in Q4 2025.
• Historically, Consolidated Net Income has averaged $62.7 million across 5 years, with a median of $92.1 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Consolidated Net Income surged 48.94% in 2022, then plunged 213.12% in 2024.
• A 5-year view of Consolidated Net Income shows it stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then decreased by 0.08% to $189.0 million in 2023, then slumped by 213.12% to -$213.7 million in 2024, then decreased by 29.26% to -$276.3 million in 2025.
• The last three Consolidated Net Income figures came in at -$276.3 million (Q4 2025), $55.6 million (Q3 2025), and $52.7 million (Q2 2025), per Business Quant data.